Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)
the ARTEMIS 2 Study Group
Research output: Contribution to journal › Article › peer-review
45Scopus
citations
Fingerprint
Dive into the research topics of 'Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)'. Together they form a unique fingerprint.